27th Sep 2006 17:40
GlaxoSmithKline PLC27 September 2006 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons I give below details of changes in the interests of Directors, PersonsDischarging Managerial Responsibility or Connected Persons in the OrdinaryShares of GlaxoSmithKline plc. 22 September 2006 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), sold 2,386 Ordinary Shares in the Company on behalf of participants in the GlaxoSmithKline Share Value Plan at a price of £14.22 per share. 22 September 2006 The GSK Trust transferred 9,562 Ordinary Shares to participants in the GlaxoSmithKline Share Value Plan. The Company was advised of these transactions on 26 September 2006. 25 September 2006 Abacus (GSK) Trustees Limited, as trustee of the GlaxoSmithKline Employee Trust, ("the GSK Trust"), transferred 18,750 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. 25 September 2006 The GSK Trust transferred 5,095 Ordinary Shares in the Company to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on 27 September 2006. The GSK Trust is a discretionary trust of which all employees or formeremployees of GlaxoSmithKline plc and its subsidiaries are potentialbeneficiaries. Three of the Company's directors, Dr J-P Garnier, Dr M M Slaouiand Mr J S Heslop are therefore interested in the shares held in the GSK Trustfrom time to time in the same way as other employees or former employees ofGlaxoSmithKline plc and its subsidiaries. This notification relates to a transaction notified in accordance withDisclosure Rule 3.1.4R(1)(b). S M Bicknell Company Secretary 27 September 2006 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline